Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

573 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A very rare cancer in Down syndrome: medulloblastoma. Epidemiological data from 13 countries.
Satgé D, Stiller CA, Rutkowski S, von Bueren AO, Lacour B, Sommelet D, Nishi M, Massimino M, Garré ML, Moreno F, Hasle H, Jakab Z, Greenberg M, von der Weid N, Kuehni C, Zurriaga O, Vicente ML, Peris-Bonet R, Benesch M, Vekemans M, Sullivan SG, Rickert C. Satgé D, et al. Among authors: massimino m. J Neurooncol. 2013 Mar;112(1):107-14. doi: 10.1007/s11060-012-1041-y. Epub 2013 Jan 11. J Neurooncol. 2013. PMID: 23307327 Free article.
Phase II trial of temozolomide in children with recurrent high-grade glioma.
Ruggiero A, Cefalo G, Garré ML, Massimino M, Colosimo C, Attinà G, Lazzareschi I, Maurizi P, Ridola V, Mazzarella G, Caldarelli M, Di Rocco C, Madon E, Abate ME, Clerico A, Sandri A, Riccardi R. Ruggiero A, et al. Among authors: massimino m. J Neurooncol. 2006 Mar;77(1):89-94. doi: 10.1007/s11060-005-9011-2. J Neurooncol. 2006. PMID: 16292488 Clinical Trial.
Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome--a new clinical perspective.
Garrè ML, Cama A, Bagnasco F, Morana G, Giangaspero F, Brisigotti M, Gambini C, Forni M, Rossi A, Haupt R, Nozza P, Barra S, Piatelli G, Viglizzo G, Capra V, Bruno W, Pastorino L, Massimino M, Tumolo M, Fidani P, Dallorso S, Schumacher RF, Milanaccio C, Pietsch T. Garrè ML, et al. Among authors: massimino m. Clin Cancer Res. 2009 Apr 1;15(7):2463-71. doi: 10.1158/1078-0432.CCR-08-2023. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276247
Childhood medulloblastoma.
Massimino M, Giangaspero F, Garrè ML, Gandola L, Poggi G, Biassoni V, Gatta G, Rutkowski S. Massimino M, et al. Crit Rev Oncol Hematol. 2011 Jul;79(1):65-83. doi: 10.1016/j.critrevonc.2010.07.010. Epub 2010 Dec 3. Crit Rev Oncol Hematol. 2011. PMID: 21129995 Review.
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial.
Lannering B, Rutkowski S, Doz F, Pizer B, Gustafsson G, Navajas A, Massimino M, Reddingius R, Benesch M, Carrie C, Taylor R, Gandola L, Björk-Eriksson T, Giralt J, Oldenburger F, Pietsch T, Figarella-Branger D, Robson K, Forni M, Clifford SC, Warmuth-Metz M, von Hoff K, Faldum A, Mosseri V, Kortmann R. Lannering B, et al. Among authors: massimino m. J Clin Oncol. 2012 Sep 10;30(26):3187-93. doi: 10.1200/JCO.2011.39.8719. Epub 2012 Jul 30. J Clin Oncol. 2012. PMID: 22851561 Clinical Trial.
Spinal cord ependymomas in children and adolescents.
Benesch M, Frappaz D, Massimino M. Benesch M, et al. Among authors: massimino m. Childs Nerv Syst. 2012 Dec;28(12):2017-28. doi: 10.1007/s00381-012-1908-4. Epub 2012 Sep 8. Childs Nerv Syst. 2012. PMID: 22961356 Review.
Predictors of outcome in an AIEOP series of childhood ependymomas: a multifactorial analysis.
Modena P, Buttarelli FR, Miceli R, Piccinin E, Baldi C, Antonelli M, Morra I, Lauriola L, Di Rocco C, Garrè ML, Sardi I, Genitori L, Maestro R, Gandola L, Facchinetti F, Collini P, Sozzi G, Giangaspero F, Massimino M. Modena P, et al. Among authors: massimino m. Neuro Oncol. 2012 Nov;14(11):1346-56. doi: 10.1093/neuonc/nos245. Epub 2012 Oct 17. Neuro Oncol. 2012. PMID: 23076205 Free PMC article.
Quality of survival and growth in children and young adults in the PNET4 European controlled trial of hyperfractionated versus conventional radiation therapy for standard-risk medulloblastoma.
Kennedy C, Bull K, Chevignard M, Culliford D, Dörr HG, Doz F, Kortmann RD, Lannering B, Massimino M, Navajas Gutiérrez A, Rutkowski S, Spoudeas HA, Calaminus G; PNET4 study group of the Brain Tumour Group of The European branch of the International Society of Paediatric Oncology (SIOP-E). Kennedy C, et al. Among authors: massimino m. Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):292-300. doi: 10.1016/j.ijrobp.2013.09.046. Epub 2013 Nov 13. Int J Radiat Oncol Biol Phys. 2014. PMID: 24239386 Clinical Trial.
Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial.
Cefalo G, Massimino M, Ruggiero A, Barone G, Ridola V, Spreafico F, Potepan P, Abate ME, Mascarin M, Garrè ML, Perilongo G, Madon E, Colosimo C, Riccardi R. Cefalo G, et al. Among authors: massimino m. Neuro Oncol. 2014 May;16(5):748-53. doi: 10.1093/neuonc/not320. Epub 2014 Jan 30. Neuro Oncol. 2014. PMID: 24482446 Free PMC article. Clinical Trial.
573 results